Decoding the Inflammatory Pathway in Heart Failure: The Role of Interleukins and Tumor Necrosis Factor-Alpha in Disease Severity
Entschlüsselung des inflammatorischen Signalwegs bei Herzinsuffizienz: Die Rolle von Interleukinen und Tumornekrosefaktor-Alpha bei der Krankheits-schwere
Journal of Clinical Medicine · 28.08.2025 · 14 (17) · 6092
DOI: 10.3390/jcm14176092 ↗Auf einen Blick
Bei 61 Patient:innen mit Herzinsuffizienz waren IL-1, IL-6 und TNF-α höher als bei 65 Kontrollen. Höhere Spiegel waren mit niedrigerer LVEF und fortgeschrittenerer NYHA-Klasse verbunden.
Fragestellung
Wurden Serumspiegel von IL-1, IL-6 und TNF-α bei Herzinsuffizienz im Vergleich zu Kontrollen und in Beziehung zur LVEF untersucht?
Methode
Fall-Kontroll-Studie am Madinah Cardiac Center zwischen Oktober 2024 und April 2025; Messung von IL-1, IL-6 und TNF-α per ELISA; Erfassung klinischer Parameter einschließlich LVEF.
Ergebnisse
IL-1: 6,77 ± 1,17 vs. 1,27 ± 0,42 pg/mL; IL-6: 54,12 ± 4,64 vs. 9,29 ± 1,72 pg/mL; TNF-α: 235,56 ± 18,88 vs. 67,37 ± 6,28 pg/mL; jeweils p < 0,001.
Schlussfolgerung der Autor:innen
Die deutliche Erhöhung von IL-1, IL-6 und TNF-α bei Herzinsuffizienz unterstreicht die wichtige Rolle der Entzündung bei Krankheitsprogression und -schwere.
Kernaussagen
- IL-1, IL-6 und TNF-α waren bei Herzinsuffizienz erhöht
- Höhere Markerwerte gingen mit niedrigerer LVEF einher
- Zusammenhang auch mit fortgeschrittenerer NYHA-Klasse
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.08.2025. Verfasst von Sameh A Ahmed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 30001, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taibah University.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background/Objectives: Heart failure (HF) remains a major global cause of morbidity and mortality, exerting substantial health and economic burdens. Increasing evidence suggests that systemic inflammation plays a pivotal role in HF pathophysiology, with key cytokines; interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) contributing to disease progression and worsening cardiac function. This study aimed to evaluate serum levels of IL-1, IL-6, and TNF-α in patients with HF compared to control subjects, to assess differences in these inflammatory mediators between groups, and to explore their relationship with left ventricular ejection fraction (LVEF).
Methods
A case–control study was conducted at the Madinah Cardiac Center between October 2024 and April 2025, including 61 patients diagnosed with HF and 65 age- and sex-matched controls without HF. Serum concentrations of IL-1, IL-6, and TNF-α were measured using enzyme-linked immunosorbent assay (ELISA). Clinical parameters, including LVEF and echocardiographic data, were recorded and analyzed.
Results
Patients with HF demonstrated significantly elevated levels of IL-1 (6.77 ± 1.17 vs. 1.27 ± 0.42 pg/mL, p < 0.001), IL-6 (54.12 ± 4.64 vs. 9.29 ± 1.72 pg/mL, p < 0.001), and TNF-α (235.56 ± 18.88 vs. 67.37 ± 6.28 pg/mL, p < 0.001) compared to controls. Higher inflammatory marker levels were associated with reduced LVEF and more advanced New York Heart Association (NYHA) functional class, indicating a clear link between systemic inflammation and HF severity.
Conclusions
The significant elevation of IL-1, IL-6, and TNF-α in HF patients highlights the pivotal role of inflammation in disease progression and severity, offering valuable insights into the underlying mechanisms that may inform future therapeutic strategies. By providing a comprehensive evaluation of these key pro-inflammatory cytokines in relation to LVEF, this study presents an integrated perspective on the inflammatory profile associated with HF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 30001, Saudi Arabia.
- Department of Internal Medicine, College of Medicine, Taibah University, Al-Madinah Al-Munawarah 30001, Saudi Arabia.
- Adult Cardiology, Madinah Cardiac Center, Al-Madinah Al-Munawara 42351, Saudi Arabia.
ORCID-Profile: Sameh A Ahmed, Hussein M Ismail
Förderung
- Taibah University
Zitieren
APA
Ahmed, S. A., Ismail, H. M., Alahmedi, A. B., Alahmadi, F. B., Muhawish, A. F., Alsubhi, A. A., Almohammadi, Y. S., Alwusaidi, A. K., Alsaedi, A. S., Alhazmi, T. G., & Busra, M. N. (2025). Decoding the Inflammatory Pathway in Heart Failure: The Role of Interleukins and Tumor Necrosis Factor-Alpha in Disease Severity. Journal of Clinical Medicine, 14(17), 6092. https://doi.org/10.3390/jcm14176092
Vancouver
Ahmed SA, Ismail HM, Alahmedi AB, Alahmadi FB, Muhawish AF, Alsubhi AA, et al. Decoding the Inflammatory Pathway in Heart Failure: The Role of Interleukins and Tumor Necrosis Factor-Alpha in Disease Severity. Journal of Clinical Medicine. 2025;14(17):6092. doi:10.3390/jcm14176092
BibTeX
@article{Ahmed2025,
author = {Ahmed, Sameh A and Ismail, Hussein M and Alahmedi, Ahmed B and Alahmadi, Faisal B and Muhawish, Abdulaziz F and Alsubhi, Abed A and Almohammadi, Yazeed S and Alwusaidi, Abdulrahman K and Alsaedi, Abdullah S and Alhazmi, Tariq G and Busra, Mohammed N},
title = {Decoding the Inflammatory Pathway in Heart Failure: The Role of Interleukins and Tumor Necrosis Factor-Alpha in Disease Severity},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {17},
pages = {6092},
doi = {10.3390/jcm14176092}
}
EUVIMED